NCT02715882 - Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

February 28, 2017

Study Completion Date

December 31, 2017

Conditions

Colorectal Cancer

Interventions

DRUG

CBLB502

DRUG

Placebo

Trial Locations (1)

Unknown

"Federal State Budgetary Institution State Scientific Center of Coloproctology named after A.N. Ryzhikh Ministry of Health of the Russian Federation", Moscow